요실금 디바이스 시장 보고서 : 제품, 카테고리, 요실금 유형, 환자, 최종사용자, 지역별(2024-2032년)

The global urinary incontinence devices market size reached US$ 3.0 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 6.8 Billion by 2032, exhibiting a growth rate (CAGR) of 9.3% during 2024-2032. The growing occurrence of neurological diseases, diabetes, and obesity; increasing number of individuals who are addicted to smoking and alcohol consumption, and rising preference of patients to opt for minimally invasive (MI) treatment options represent some of the key factors driving the market.

Urinary incontinence devices are used by patients suffering from urinary incontinence leading to involuntary loss of urine. They comprise a wide variety of devices that work either by restricting the passage of urine or by changing the position of the bladder and urethra to control the bladder effectively. They also consist of various purpose-based devices for female patients, such as a pessary, which is a latex or silicon component that can be inserted into the vagina to treat stress incontinence and support the bladder. Urinary incontinence devices include an artificial urinary sphincter, which is a tiny device surgically implanted inside men to provide stress incontinence treatment. They are manufactured in various forms, such as donut and cube shapes, and must be fitted by a doctor. They are also produced in the form of small plugs, which are inserted into the urethra to prevent bladder leakage and are removed prior to urination. They are often paired with other incontinence treatments, such as Kegel exercises, medications, and specific bladder training.

Urinary Incontinence Devices Market Trends:

At present, the increasing demand for urinary incontinence devices, as they are safe, reliable, and effective, represents one of the key factors supporting the market growth. Besides this, the rising occurrence of neurological diseases, diabetes, and obesity due to the adoption of unhealthy lifestyle habits and consumption of caffeine, sweeteners, chocolate, carbonated drinks, sparkling water, and muscle relaxants is propelling the growth of the market. In addition, the growing number of individuals who are addicted to smoking and alcohol consumption is offering a favorable market outlook. Apart from this, the rising occurrence of urinary incontinence among senior citizens is contributing to the growth of the market. Additionally, the increasing employment of at-home devices to treat stress, urge, and bowel incontinence is strengthening the growth of the market. Additionally, the rising preference of patients to opt for MI minimally invasive treatment options, as they reduce the duration of hospital stays and minimize postoperative scarring, is impelling the growth of the market. Moreover, the increasing awareness about the beneficial aspects of early diagnosis of urinary incontinence and the utilization of various electrical stimulation devices to manage the condition are bolstering the growth of the market.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global urinary incontinence devices market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on product, category, incontinence type, patient and end user.

Product Insights:

• Urinary Catheters
• Vaginal Slings
• Electrical Stimulation Devices
• Artificial Urinary Sphincters
• Others

The report has provided a detailed breakup and analysis of the urinary incontinence devices market based on the product. This includes urinary catheters, vaginal slings, electrical stimulation devices, artificial urinary sphincters, and others. According to the report, vaginal slings represented the largest segment.

Category Insights:

• External Urinary Incontinence Devices
• Internal Urinary Incontinence Devices

A detailed breakup and analysis of the urinary incontinence devices market based on the category has also been provided in the report. This includes external urinary incontinence devices and internal urinary incontinence devices. According to the report, internal urinary incontinence devices accounted for the largest market share.

Incontinence Type Insights:

• Stress Urinary Incontinence
• Urge Urinary Incontinence
• Overflow Urinary Incontinence
• Mixed Incontinence

A detailed breakup and analysis of the urinary incontinence devices market based on the incontinence type has also been provided in the report. This includes stress urinary incontinence, urge urinary incontinence, overflow urinary incontinence, and mixed incontinence. According to the report, stress urinary incontinence accounted for the largest market share.

Patient Insights:

• Female
• Male

A detailed breakup and analysis of the urinary incontinence devices market based on the patient has also been provided in the report. This includes female and male. According to the report, female accounted for the largest market share.

End User Insights:

• Hospitals
• Ambulatory Surgical Centers
• Others

A detailed breakup and analysis of the urinary incontinence devices market based on the end user has also been provided in the report. This includes hospitals, ambulatory surgical centers, and others. According to the report, hospitals accounted for the largest market share.

Regional Insights:

• North America
  • United States
  • Canada
• Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
• Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
• Latin America
  • Brazil
  • Mexico
  • Others
• Middle East and Africa

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America (the United States and Canada) was the largest market for urinary incontinence devices. Some of the factors driving the North America urinary incontinence devices market included the growing advancements in the healthcare sector, rising demand for minimally invasive (MI) medical procedures, increasing availability of favorable medical reimbursement policies, etc.

Competitive Landscape:

The report has also provided a comprehensive analysis of the competitive landscape in the global urinary incontinence devices market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include B. Braun Melsungen AG, Baxter International Inc, Becton Dickinson and Company, Boston Scientific Corporation, Caldera Medical Inc., Coloplast A/S, ConvaTec Group plc, Cook Group Inc., Johnson & Johnson, Kimberly-Clark Corporation, Laborie Medical Technologies Inc., Medtronic plc, Teleflex Incorporated, etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report

• 1. What was the size of the global urinary incontinence devices market in 2023?
• 2. What is the expected growth rate of the global urinary incontinence devices market during 2024-2032?
• 3. What are the key factors driving the global urinary incontinence devices market?
• 4. What has been the impact of COVID-19 on the global urinary incontinence devices market?
• 5. What is the breakup of the global urinary incontinence devices market based on the product?
• 6. What is the breakup of the global urinary incontinence devices market based on the category?
• 7. What is the breakup of the global urinary incontinence devices market based on the incontinence type?
• 8. What is the breakup of the global urinary incontinence devices market based on the patient?
• 9. What is the breakup of the global urinary incontinence devices market based on the end user?
• 10. What are the key regions in the global urinary incontinence devices market?
• 11. Who are the key players/companies in the global urinary incontinence devices market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Urinary Incontinence Devices Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Product

• 6.1 Urinary Catheters
  • 6.1.1 Market Trends
  • 6.1.2 Market Forecast
• 6.2 Vaginal Slings
  • 6.2.1 Market Trends
  • 6.2.2 Market Forecast
• 6.3 Electrical Stimulation Devices
  • 6.3.1 Market Trends
  • 6.3.2 Market Forecast
• 6.4 Artificial Urinary Sphincters
  • 6.4.1 Market Trends
  • 6.4.2 Market Forecast
• 6.5 Others
  • 6.5.1 Market Trends
  • 6.5.2 Market Forecast

7 Market Breakup by Category

• 7.1 External Urinary Incontinence Devices
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Internal Urinary Incontinence Devices
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast

8 Market Breakup by Incontinence Type

• 8.1 Stress Urinary Incontinence
  • 8.1.1 Market Trends
  • 8.1.2 Market Forecast
• 8.2 Urge Urinary Incontinence
  • 8.2.1 Market Trends
  • 8.2.2 Market Forecast
• 8.3 Overflow Urinary Incontinence
  • 8.3.1 Market Trends
  • 8.3.2 Market Forecast
• 8.4 Mixed Incontinence
  • 8.4.1 Market Trends
  • 8.4.2 Market Forecast

9 Market Breakup by Patient

• 9.1 Female
  • 9.1.1 Market Trends
  • 9.1.2 Market Forecast
• 9.2 Male
  • 9.2.1 Market Trends
  • 9.2.2 Market Forecast

10 Market Breakup by End User

• 10.1 Hospitals
  • 10.1.1 Market Trends
  • 10.1.2 Market Forecast
• 10.2 Ambulatory Surgical Centers
  • 10.2.1 Market Trends
  • 10.2.2 Market Forecast
• 10.3 Others
  • 10.3.1 Market Trends
  • 10.3.2 Market Forecast

11 Market Breakup by Region

• 11.1 North America
  • 11.1.1 United States
    • 11.1.1.1 Market Trends
    • 11.1.1.2 Market Forecast
  • 11.1.2 Canada
    • 11.1.2.1 Market Trends
    • 11.1.2.2 Market Forecast
• 11.2 Asia-Pacific
  • 11.2.1 China
    • 11.2.1.1 Market Trends
    • 11.2.1.2 Market Forecast
  • 11.2.2 Japan
    • 11.2.2.1 Market Trends
    • 11.2.2.2 Market Forecast
  • 11.2.3 India
    • 11.2.3.1 Market Trends
    • 11.2.3.2 Market Forecast
  • 11.2.4 South Korea
    • 11.2.4.1 Market Trends
    • 11.2.4.2 Market Forecast
  • 11.2.5 Australia
    • 11.2.5.1 Market Trends
    • 11.2.5.2 Market Forecast
  • 11.2.6 Indonesia
    • 11.2.6.1 Market Trends
    • 11.2.6.2 Market Forecast
  • 11.2.7 Others
    • 11.2.7.1 Market Trends
    • 11.2.7.2 Market Forecast
• 11.3 Europe
  • 11.3.1 Germany
    • 11.3.1.1 Market Trends
    • 11.3.1.2 Market Forecast
  • 11.3.2 France
    • 11.3.2.1 Market Trends
    • 11.3.2.2 Market Forecast
  • 11.3.3 United Kingdom
    • 11.3.3.1 Market Trends
    • 11.3.3.2 Market Forecast
  • 11.3.4 Italy
    • 11.3.4.1 Market Trends
    • 11.3.4.2 Market Forecast
  • 11.3.5 Spain
    • 11.3.5.1 Market Trends
    • 11.3.5.2 Market Forecast
  • 11.3.6 Russia
    • 11.3.6.1 Market Trends
    • 11.3.6.2 Market Forecast
  • 11.3.7 Others
    • 11.3.7.1 Market Trends
    • 11.3.7.2 Market Forecast
• 11.4 Latin America
  • 11.4.1 Brazil
    • 11.4.1.1 Market Trends
    • 11.4.1.2 Market Forecast
  • 11.4.2 Mexico
    • 11.4.2.1 Market Trends
    • 11.4.2.2 Market Forecast
  • 11.4.3 Others
    • 11.4.3.1 Market Trends
    • 11.4.3.2 Market Forecast
• 11.5 Middle East and Africa
  • 11.5.1 Market Trends
  • 11.5.2 Market Breakup by Country
  • 11.5.3 Market Forecast

12 SWOT Analysis

• 12.1 Overview
• 12.2 Strengths
• 12.3 Weaknesses
• 12.4 Opportunities
• 12.5 Threats

13 Value Chain Analysis

14 Porters Five Forces Analysis

• 14.1 Overview
• 14.2 Bargaining Power of Buyers
• 14.3 Bargaining Power of Suppliers
• 14.4 Degree of Competition
• 14.5 Threat of New Entrants
• 14.6 Threat of Substitutes

15 Price Analysis

16 Competitive Landscape

• 16.1 Market Structure
• 16.2 Key Players
• 16.3 Profiles of Key Players
  • 16.3.1 B. Braun Melsungen AG
    • 16.3.1.1 Company Overview
    • 16.3.1.2 Product Portfolio
    • 16.3.1.3 SWOT Analysis
  • 16.3.2 Baxter International Inc
    • 16.3.2.1 Company Overview
    • 16.3.2.2 Product Portfolio
    • 16.3.2.3 Financials
    • 16.3.2.4 SWOT Analysis
  • 16.3.3 Becton Dickinson and Company
    • 16.3.3.1 Company Overview
    • 16.3.3.2 Product Portfolio
    • 16.3.3.3 Financials
    • 16.3.3.4 SWOT Analysis
  • 16.3.4 Boston Scientific Corporation
    • 16.3.4.1 Company Overview
    • 16.3.4.2 Product Portfolio
    • 16.3.4.3 Financials
    • 16.3.4.4 SWOT Analysis
  • 16.3.5 Caldera Medical Inc.
    • 16.3.5.1 Company Overview
    • 16.3.5.2 Product Portfolio
  • 16.3.6 Coloplast A/S
    • 16.3.6.1 Company Overview
    • 16.3.6.2 Product Portfolio
    • 16.3.6.3 Financials
    • 16.3.6.4 SWOT Analysis
  • 16.3.7 ConvaTec Group plc
    • 16.3.7.1 Company Overview
    • 16.3.7.2 Product Portfolio
    • 16.3.7.3 Financials
  • 16.3.8 Cook Group Inc.
    • 16.3.8.1 Company Overview
    • 16.3.8.2 Product Portfolio
  • 16.3.9 Johnson & Johnson
    • 16.3.9.1 Company Overview
    • 16.3.9.2 Product Portfolio
    • 16.3.9.3 Financials
    • 16.3.9.4 SWOT Analysis
  • 16.3.10 Kimberly-Clark Corporation
    • 16.3.10.1 Company Overview
    • 16.3.10.2 Product Portfolio
    • 16.3.10.3 Financials
    • 16.3.10.4 SWOT Analysis
  • 16.3.11 Laborie Medical Technologies Inc.
    • 16.3.11.1 Company Overview
    • 16.3.11.2 Product Portfolio
  • 16.3.12 Medtronic plc
    • 16.3.12.1 Company Overview
    • 16.3.12.2 Product Portfolio
    • 16.3.12.3 Financials
    • 16.3.12.4 SWOT Analysis
  • 16.3.13 Teleflex Incorporated
    • 16.3.13.1 Company Overview
    • 16.3.13.2 Product Portfolio
    • 16.3.13.3 Financials
    • 16.3.13.4 SWOT Analysis